Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Cell Therapy Enhancement of Microfracture Surgery

NCT01799876 is registered in ClinicalTrials.gov with Fondren Orthopedic Group L.L.P. as lead sponsor.

NCT NCT01799876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01799876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Cell Therapy Enhancement of Microfracture Surgery
Lead sponsor
Fondren Orthopedic Group L.L.P.
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2013
Completion date
August 31, 2017
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

articular cartilage defect grade iii or iv of the knee